MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 25, 2005; DOI: 10.1124/mol.105.019125


0026-895X/06/6902-532-538$20.00
Mol Pharmacol 69:532-538, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019125v1
69/2/532    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ta, T. A.
Right arrow Articles by Pessah, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ta, T. A.
Right arrow Articles by Pessah, I. N.

Hydroxylated Xestospongins Block Inositol-1,4,5-trisphosphate-Induced Ca2+ Release and Sensitize Ca2+-Induced Ca2+ Release Mediated by Ryanodine Receptors

Tram Anh Ta, Wei Feng, Tadeusz F. Molinski, and Isaac N. Pessah

Center for Children's Environmental Health (T.A.T., I.N.P.), Department of Veterinary-Molecular Biosciences (T.A.T., W.F., I.N.P.), and Department of Chemistry (T.F.M.), University of California, Davis, California

Inositol-1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) often coexist within the endoplasmic/sarcoplasmic reticulum (ER/SR) membrane and coordinate precise spatial and temporal coding of Ca2+ signals in most animal cells. Xestospongin C (XeC) was shown to selectively block IP3-induced Ca2+ release and IP3R-mediated signaling (Gafni et al., 1997). We have further studied the specificity of xestospongin structures possessing ring hydroxyl (-OH) substituents toward IP3R, RyR, and ER/SR Ca2+-ATPase (SERCA) activities. XeC potently inhibits IP3R, weakly inhibits RyR1, and lacks activity toward SERCA1 and SERCA2. XeD (9-OH XeC), 7-OH-XeA, and araguspongin C isolated from the marine sponge Xestospongia species also inhibit IP3-mediated Ca2+ release and lack activity toward SERCA. However, these hydroxylated derivatives possess a unique activity in that they enhance Ca2+-induced Ca2+ release from SR vesicles by a mechanism involving the sensitization of RyR1 channels within the same concentration range needed to block IP3-induced Ca2+ release. These results show that xestospongins and related structures lack direct SERCA inhibitory activity, as suggested by some previous studies. A new finding is that XeD and related structures possessing a hydroxylated oxaquinolizidine ring are IP3R blockers that also enhance Ca2+-induced Ca2+ release mediated by RyRs. In intact cells, the actions of XeD are blocked by ryanodine pretreatment and do not interfere with thapsigargin-mediated Ca2+ mobilization stemming from SERCA block. Hydroxylated bis-oxaquinolizadine derivatives isolated from Xestospongia species are novel bifunctional reagents that may be useful in ascertaining how IP3Rs and RyRs contribute to cell signaling.


Received September 19, 2005; accepted October 21, 2005

Address correspondence to: Dr. Isaac Pessah, Department of VM: Molecular Biosciences University of California, Davis, 1 Shields Avenue, Davis, CA 95616. E-mail: inpessah{at}ucdavis.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Steinmann, M. L. Landsverk, J. M. Barral, and D. Boehning
Requirement of Inositol 1,4,5-Trisphosphate Receptors for Tumor-mediated Lymphocyte Apoptosis
J. Biol. Chem., May 16, 2008; 283(20): 13506 - 13509.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics